Skip to main content
. Author manuscript; available in PMC: 2022 Dec 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2020 Sep 16;19(12):2469–2480. doi: 10.1016/j.cgh.2020.09.023

Table 2.

Evidence for defective bacterial clearance by innate immunity as an early event in the pathogenesis of Crohn’s disease

❑ Genetic polymorphisms in various genes associated with bacterial handling modify the risk for developing Crohn’s disease
❑ Monogenic disorders that affect innate immunity pathways are associated with development of CD-like intestinal inflammation
❑ Defective and delayed acute response to injury in patients with sporadic CD
❑ Protective roles of innate cytokine during acute injury/repair (as opposed to proinflammatory roles in chronic inflammation)
❑ De novo development of IBD-like lesions in patients treated with targeted biological therapies